schizophrenia

Schizophrenia is a long-term mental health condition that causes a range of different psychological symptoms. These include: hallucinations (hearing or seeing things that do not exist), delusions (unusual beliefs that are not based on reality and often contradict the evidence), muddled thoughts based on the hallucinations or delusions, and changes in behaviour. Doctors describe schizophrenia as a psychotic illness. This means that sometimes a person may not be able to distinguish their own thoughts and ideas from reality.

Our schizophrenia Blogs

#MindfulnessMonday – Mindfulness moderately effective for reducing symptoms of psychosis, though controlled studies less convincing

75 Responses »
Profile photo of Sarah Knowles
Posted by
shutterstock_119557528

Last week, Elly O’Brien blogged about mindfulness-based cognitive therapy (MBCT) for various physical and psychological disorders. Today, another paper from the same authors, looking at the more broadly defined ‘mindfulness interventions’ for psychosis. Elly talked about the use of mindfulness to escape the “emotional quicksand” of negative thoughts, and the authors here again focus on [read the full story…]

Systematic review of fluphenazine for schizophrenia: 50 years of learning not that much

42 Responses »
Kathryn Walsh
Posted by
shutterstock_141125920

Antipsychotic medications are often the first line of treatment for schizophrenia and have been effective at treating florid symptoms such as delusions and hallucinations. Fluphenazine was one of the first antipsychotics to become available on the market and has now been appearing on prescriptions for over 5 decades. Despite the arrival of newer generations of [read the full story…]

Adherence therapy no more cost-effective than health education for people with schizophrenia

39 Responses »
Profile photo of Christopher Sampson
Posted by
shutterstock_115230874

When two interventions are demonstrably equivalent in terms of clinical outcomes, it is unclear which should be provided. One obvious decision rule in this case is to implement the intervention that is least costly and therefore most cost-effective. A recent economic evaluation by Patel and colleagues estimates the cost-effectiveness of adherence therapy for people with [read the full story…]

Vitamin D deficiency in psychosis: our current (limited) understanding according to the latest meta-analysis.

77 Responses »
Emma Cernis
Posted by

Get ready to amend your dopamine hypothesis and stop trying to wrap your neurons around the role of glutamate in the brain.  The rising star of the neurobiological schizophrenia literature is…. Vitamin D.  Yes, really. The more sceptical amongst you (including me) may feel that finding a vitamin deficiency in psychosis patients is perhaps not [read the full story…]

Can assessing and acting on quality of life scores improve patient satisfaction? New study concludes yes, but the results actually say no

35 Responses »
Alex Langford
Posted by
shutterstock_108332819

For mental health patients, quality of life (QoL) can include many things like self-esteem, autonomy, satisfaction with the care they’re receiving and the staff who are caring from them, reduced symptoms, minimal side-effects from treatment and good overall functioning. Measuring QoL can pick up on difficulties a patient is having that wouldn’t have otherwise come [read the full story…]

UK survey finds that social firms may help with vocational recovery for people with mental illness

45 Responses »
Liz Hughes
Posted by
shutterstock_101909887

In the UK it is a shocking statistic that around 80-90% of people with severe mental illness are not in work.  Unemployment impacts negatively not only on the individual, but is also costly to the government. Employment is now embedded in key mental health policy as a central part of recovery. However, despite this, and [read the full story…]

Systematic review: which anti-psychotic medication is the best?

88 Responses »
Profile photo of John Baker
Posted by
Pills

Schizophrenia is considered a chronic long-term debilitating condition, affecting about 1% of the population. There has been considerable debate about which of the anti-psychotic medications are the best treatments. The debate has usually been structured around typical (older) and atypical (newer) anti-psychotic medications. The revised NICE guidelines (2009) moved towards a more neutral stance between [read the full story…]

Do interventions proven to improve cardiovascular disease outcomes work for individuals with severe mental illness?

23 Responses »
Amy Green
Posted by
shutterstock_high blood pressure

Individuals with severe mental illness (SMI) have shortened life expectancies compared to the general population. This is partly down to higher rates of chronic physical illness. Cardiovascular disease (CVD) is the leading cause of death among patients using mental health services. It is assumed that interventions used to reduce CVD are similarly effective in patients with [read the full story…]

Cochrane review finds quetiapine is equivalent in efficacy to typical antipsychotics and possibly causes fewer side effects

39 Responses »
Emma Cernis
Posted by

Antipsychotic medication is the standard treatment for schizophrenia and psychosis in the UK.  Given that psychosis is commonly a chronic condition and therefore that medication used to treat it often needs to be taken for several years, getting the medication “right” is important. As I mentioned in my first blog post for the Mental Elf, [read the full story…]

A Reasoning and Rehabilitation programme reduces verbal aggression and improves problem solving in offenders with psychosis

53 Responses »
Profile photo of Christopher Pell
Posted by
Stop aggression

Here at the Mental Elf we are always on the look out for research that extends trials into new areas, and offers practical benefits to people recovering from mental illness. Within psychiatric wards violence and challenging behaviour can be extremely distressing, with a 2007 Healthcare Commission report finding that over half of staff and almost half of [read the full story…]